Since the onset of the COVID-19 pandemic in 2020, researchers have been continuously striving towards developing effective therapies to contain the virus and minimize its implications on the affected individuals. While wearing masks, social-distancing, sanitization, and vaccination remained the leading options for preventing the transmission of infections, the upsurge in the latest coronavirus mutation, Omicron
According to the World Health Organization statistics, currently approx. 463 million people are living with diabetes throughout the world. The number is set to rise to some 700 million by 2045. Diabetes is one of the leading causes of death globally, accounting for more than 79,000 deaths annually. The growing prevalence of diabetes worldwide due to poor lifestyle, inadequate physical activity,
Increasing number of COVID-19 patients across the globe to drive the growth of global remdesivir market. According to TechSci Research report, “Global Remdesivir Market By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age (Geriatric, Adult, Pediatric), By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV), By Distribution Channel (Hospitals, Clinics, Drug Stores and
Advancing biotechnological research is driving the growth in Global Nanopore Sequencing Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Nanopore Sequencing Market By Product (Consumables v/s Instruments), By Nucleotide Sequenced (DNA v/s RNA), By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing), By Type of
Advancing healthcare industry is driving the growth in Global Psychobiotics Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application
Advancing healthcare industry drives the Asia-Pacific Active Pharmaceutical Ingredient Market growth in the forecast period, 2022-2026F. According to TechSci Research report, “Asia-Pacific Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s Synthetic) By Source (Contact Manufacturing Organizations v/s In-House Manufacturing) By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others) By Molecule
Increasing health concerns post COVID infection is driving the growth if India Post COVID Health Tests Market, FY2017-FY2027. According to TechSci report on, “India Post COVID Health Tests Market By Type of Test (COVID-19 IgG Antibody Test, Hematology, Biochemistry Urea & Electrolytes, Liver Function Tests, Kidney Function Tests, Others) By Provider Type (Hospitals, Diagnostic chains, Stand-alone
Increasing prevalence of nosocomial infections and unhygienic environmental conditions are expected to drive the India anti-fungal drugs market in the forecast period. According to TechSci Research report, “India Anti-Fungal Drugs Market By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Parenteral, Topical,
Rising concerns for fertility is driving the growth in Global Ophthalmic Drugs Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Ophthalmic Drugs Market By Drug Class (Anti-Inflammatory Drugs, Anti-Infection Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others) By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Others) By Product Type (OTC Drugs v/s Prescription Drugs) By
Demand for effective therapeutics for treatment of CNS disorders is a driving factor for the growth of Global Central Nervous System Therapeutics Market in the forecast period. According to TechSci Research report, “Global Central Nervous System Therapeutics Market By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Diseases,